Lana E. Kandalaft, et al: Novel 2-step Immunotherapy Showed Promise for Recurrent Ovarian Cancer
AACR 2013 Pressconference April 6: "Late Breaking Clinical Trials"
Lana E. Kandalaft, et al: Autologous Whole-Tumor Antigen Vaccination in combination with Adoptive T cell Therapy for Patients with Recurrent Ovarian Cancer